163 related articles for article (PubMed ID: 37885034)
21. Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity.
Stange A; Mannigel I; Peters K; Heinkelein M; Stanke N; Cartellieri M; Göttlinger H; Rethwilm A; Zentgraf H; Lindemann D
J Virol; 2005 May; 79(9):5466-76. PubMed ID: 15827161
[TBL] [Abstract][Full Text] [Related]
22. The fourth central polypurine tract guides the synthesis of prototype foamy virus plus-strand DNA.
Chen D; Song J; Sun Y; Li Z; Wen D; Liu Q; Liu W; He X
Virus Genes; 2017 Apr; 53(2):259-265. PubMed ID: 28185138
[TBL] [Abstract][Full Text] [Related]
23. Prototype foamy virus elicits complete autophagy involving the ER stress-related UPR pathway.
Yuan P; Dong L; Cheng Q; Wang S; Li Z; Sun Y; Han S; Yin J; Peng B; He X; Liu W
Retrovirology; 2017 Mar; 14(1):16. PubMed ID: 28270144
[TBL] [Abstract][Full Text] [Related]
24. Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction.
Lukic DS; Hotz-Wagenblatt A; Lei J; Räthe AM; Mühle M; Denner J; Münk C; Löchelt M
Retrovirology; 2013 Jul; 10():76. PubMed ID: 23880220
[TBL] [Abstract][Full Text] [Related]
25. Heparan sulfate is an attachment factor for foamy virus entry.
Plochmann K; Horn A; Gschmack E; Armbruster N; Krieg J; Wiktorowicz T; Weber C; Stirnnagel K; Lindemann D; Rethwilm A; Scheller C
J Virol; 2012 Sep; 86(18):10028-35. PubMed ID: 22787203
[TBL] [Abstract][Full Text] [Related]
26. Residues R(199)H(200) of prototype foamy virus transactivator Bel1 contribute to its binding with LTR and IP promoters but not its nuclear localization.
Ma Q; Tan J; Cui X; Luo D; Yu M; Liang C; Qiao W
Virology; 2014 Jan; 449():215-23. PubMed ID: 24418555
[TBL] [Abstract][Full Text] [Related]
27. Differential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particles.
Stirnnagel K; Schupp D; Dupont A; Kudryavtsev V; Reh J; Müllers E; Lamb DC; Lindemann D
Retrovirology; 2012 Aug; 9():71. PubMed ID: 22935135
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of the host cellular protein transportin 3 attenuates prototype foamy virus infection.
Ali MK; Kim J; Hamid FB; Shin CG
Biosci Biotechnol Biochem; 2015; 79(6):943-51. PubMed ID: 25660973
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.
Duda A; Lüftenegger D; Pietschmann T; Lindemann D
J Virol; 2006 Aug; 80(16):8158-67. PubMed ID: 16873272
[TBL] [Abstract][Full Text] [Related]
30. Acetylation of the foamy virus transactivator Tas by PCAF augments promoter-binding affinity and virus transcription.
Bodem J; Kräusslich HG; Rethwilm A
J Gen Virol; 2007 Jan; 88(Pt 1):259-263. PubMed ID: 17170459
[TBL] [Abstract][Full Text] [Related]
31. Human Schlafen 11 exploits codon preference discrimination to attenuate viral protein synthesis of prototype foamy virus (PFV).
Guo G; Wang Y; Hu XM; Li ZR; Tan J; Qiao WT
Virology; 2021 Mar; 555():78-88. PubMed ID: 33465725
[TBL] [Abstract][Full Text] [Related]
32. Complex effects of foamy virus central purine-rich regions on viral replication.
Peters K; Barg N; Gärtner K; Rethwilm A
Virology; 2008 Mar; 373(1):51-60. PubMed ID: 18078974
[TBL] [Abstract][Full Text] [Related]
33. The cooperative function of arginine residues in the Prototype Foamy Virus Gag C-terminus mediates viral and cellular RNA encapsidation.
Hamann MV; Müllers E; Reh J; Stanke N; Effantin G; Weissenhorn W; Lindemann D
Retrovirology; 2014 Oct; 11():87. PubMed ID: 25292281
[TBL] [Abstract][Full Text] [Related]
34. The promyelocytic leukemia protein does not mediate foamy virus latency in vitro.
Meiering CD; Linial ML
J Virol; 2003 Feb; 77(3):2207-13. PubMed ID: 12525655
[TBL] [Abstract][Full Text] [Related]
35. Feline foamy virus Tas protein is a DNA-binding transactivator.
Omoto S; Brisibe EA; Okuyama H; Fujii YR
J Gen Virol; 2004 Oct; 85(Pt 10):2931-2935. PubMed ID: 15448355
[TBL] [Abstract][Full Text] [Related]
36. Subviral particle release determinants of prototype foamy virus.
Stange A; Lüftenegger D; Reh J; Weissenhorn W; Lindemann D
J Virol; 2008 Oct; 82(20):9858-69. PubMed ID: 18684814
[TBL] [Abstract][Full Text] [Related]
37. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
Russell RA; Wiegand HL; Moore MD; Schäfer A; McClure MO; Cullen BR
J Virol; 2005 Jul; 79(14):8724-31. PubMed ID: 15994766
[TBL] [Abstract][Full Text] [Related]
38. Prototype foamy virus gag nuclear localization: a novel pathway among retroviruses.
Müllers E; Stirnnagel K; Kaulfuss S; Lindemann D
J Virol; 2011 Sep; 85(18):9276-85. PubMed ID: 21715475
[TBL] [Abstract][Full Text] [Related]
39. A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid.
Goldstone DC; Flower TG; Ball NJ; Sanz-Ramos M; Yap MW; Ogrodowicz RW; Stanke N; Reh J; Lindemann D; Stoye JP; Taylor IA
PLoS Pathog; 2013 May; 9(5):e1003376. PubMed ID: 23675305
[TBL] [Abstract][Full Text] [Related]
40. Lysine residues K66, K109, and K110 in the bovine foamy virus transactivator protein are required for transactivation and viral replication.
Zhang S; Cui X; Li J; Liang Z; Qiao W; Tan J
Virol Sin; 2016 Apr; 31(2):142-9. PubMed ID: 26980333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
